New discovery of a large-sized Tetraconodon (Artiodactyla, Suidae) from the lower part of the Irrawaddy Formation, Myanmar

New fossil dentitions of a large-sized Tetraconodon (Mammalia, Artiodactyla, Suidae) were discovered from the lower part of the Irrawaddy Formation, Migyaungye Township, Magway Division, central Myanmar. These specimens are the largest among the Tetraconodon specimens ever found in Myanmar. The molar dimensions of these specimens are similar with those of Tetraconodon magnus but are smaller in the dimensions of last two premolars than T. magnus. Therefore, we assigned these specimens as Tetraconodon sp. cf. T. magnus. The occurrence of a large Tetraconodon confirms an Upper Miocene age for the lower part of the Irrawaddy Formation

Tragulidae and pecoran ruminants from the latest Middle Miocene (Sarmatian, late Astaracian) of Austria.

One of the richest and most complete European terrestrial vertebrate faunas of late Middle Miocene age (12.2¿12.0 Ma; Gross et al., in press) was found near Gratkorn, at the northeastern realm of the Styrian Basin (Austria). It is one of the rare localities from the Sarmatian sensu stricto (late Serravallian) in the Central Paratethys area with a vertebrate fauna, both high in quality as well as rich in quantity. So far, 62 taxa are recorded, including Euprox furcatus, Micromeryx flourensianus and Dorcatherium naui. This is one of the rare records of Dorcatherium naui older than Vallesian and the oldest finding of the species from the Paratethys realm so far. Up to now, Dorcatherium naui of pre-Vallesian ages have only been described from Przeworno (Poland; Glazek et al., 1971), and Abocador de Can Mata (Spain; Alba et al., 2011), which are of latest Middle Miocene age like Gratkorn. Therefore the latter does not only represent one of the oldest records of Dorcatherium naui but also supports the wide distribution of the taxon already at the latest Middle Miocene. In contrast to the site of Abocador de Can Mata, where Dorcatherium naui is an infrequent element (Alba et al., 2011), the species is abundant at the locality of Gratkorn. Apart from this the larger mammal fauna of Abocadar de Can Mata and Gratkorn is quite similar, except of proboscidean and bovid taxa. While in Abocador de Can Mata Gomphotherium, Deinotherium and bovids are present (Alba et al., 2009), in Gratkorn only Deinotherium giganteum was found until now. Bovids were found in contemporaneous sediments in the eastern Styrian Basin (Gross et al., in press), though. With the material of Gratkorn previous ideas on ecological adaptations in Dorcatherium (Rössner, 2004) are supported and the understanding of the ecological niche of the ¿forest-dweller¿ Dorcatherium is specified. Besides new ideas on dispersal, evolution and ecology of Dorcatherium the locality of Gratkorn also enables an in-depth evaluation of its species separation. The specimens from Gratkorn demonstrate, in comparison with other Material from the Paratethys area, a clear distinction between Dorcatherium crassum and Dorcatherium naui and underline the taxonomic separation of both species as accepted by several authors (e.g. Alba et al., 2011). REFERENCES Alba, D.M. et al. (2009). Middle Miocene vertebrate localities from Abocador de Can Mata (els Hostalets de Pierola, Vallès Penedès Basin, Catalonia, Spain): An update after the 2006-2008 field campaigns. Paleolusitana, 1, 59¿73. Alba, D.M. et al. (2011). Middle Miocene tragulid remains from Abocador de Can Mata: the earliest record of Dorcatherium naui from Western Europe. Geobios, 44, 135-150. Glazek, J. et al. (1971). Miocene vertebrate faunas from Przeworno (Lower Silesia) and their geological setting. Acta Geologica Polonica, 21(3), 473-516. Gross, M. et al. (in press). Gratkorn ¿ A benchmark locality for the continental Sarmatian s. str. of the Central Paratethys. International Journal of Earth Sciences, doi: 10.1007/s00531-010-0615-1. Rössner, G.E. (2004). Community structure and regional patterns in late Early to Middle Miocene Ruminantia of Central Europe. Courier Forschungs-Institut Senckenberg, 249: 91-100.Peer Reviewe

Red clover (Trifolium pratense L.) draft genome provides a platform for trait improvement

Red clover (Trifolium pratense L.) is a globally significant forage legume in pastoral livestock farming systems. It is an attractive component of grassland farming, because of its high yield and protein content, nutritional value and ability to fix atmospheric nitrogen. Enhancing its role further in sustainable agriculture requires genetic improvement of persistency, disease resistance, and tolerance to grazing. To help address these challenges, we have assembled a chromosome-scale reference genome for red clover. We observed large blocks of conserved synteny with Medicago truncatula and estimated that the two species diverged ~23 million years ago. Among the 40,868 annotated genes, we identified gene clusters involved in biochemical pathways of importance for forage quality and livestock nutrition. Genotyping by sequencing of a synthetic population of 86 genotypes show that the number of markers required for genomics-based breeding approaches is tractable, making red clover a suitable candidate for association studies and genomic selection

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Objective: Having demonstrated short-term weight loss with liraglutide in this group of obese adults, we now evaluate safety/tolerability (primary outcome) and long-term efficacy for sustaining weight loss (secondary outcome) over 2 years. <p/>Design: A randomized, double-blind, placebo-controlled 20-week study with 2-year extension (sponsor unblinded at 20 weeks, participants/investigators at 1 year) in 19 European clinical research centers. <p/>Subjects: A total of 564 adults (n=90–98 per group; body mass index 30–40 kg m−2) enrolled, 398 entered the extension and 268 completed the 2-year trial. Participants received diet (500 kcal deficit per day) and exercise counseling during 2-week run-in, before being randomly assigned (with a telephone or web-based system) to once-daily subcutaneous liraglutide (1.2, 1.8, 2.4 or 3.0 mg, n=90–95), placebo (n=98) or open-label orlistat (120 mg × 3, n=95). After 1 year, liraglutide/placebo recipients switched to liraglutide 2.4 mg, then 3.0 mg (based on 20-week and 1-year results, respectively). The trial ran from January 2007–April 2009 and is registered with Clinicaltrials.gov, number NCT00480909. <p/>Results: From randomization to year 1, liraglutide 3.0 mg recipients lost 5.8 kg (95% confidence interval 3.7–8.0) more weight than those on placebo and 3.8 kg (1.6–6.0) more than those on orlistat (Pless than or equal to0.0001; intention-to-treat, last-observation-carried-forward). At year 2, participants on liraglutide 2.4/3.0 mg for the full 2 years (pooled group, n=184) lost 3.0 kg (1.3–4.7) more weight than those on orlistat (n=95; P<0.001). Completers on liraglutide 2.4/3.0 mg (n=92) maintained a 2-year weight loss of 7.8 kg from screening. With liraglutide 3.0 mg, 20-week body fat decreased by 15.4% and lean tissue by 2.0%. The most frequent drug-related side effects were mild to moderate, transient nausea and vomiting. With liraglutide 2.4/3.0 mg, the 2-year prevalence of prediabetes and metabolic syndrome decreased by 52 and 59%, with improvements in blood pressure and lipids. <p/>Conclusion: Liraglutide is well tolerated, sustains weight loss over 2 years and improves cardiovascular risk factors